INDUSTRIAL
Civan Advanced Technologies
Company type: private
Location: Israel
Through a unique vertically integrated approach, Civan develops and delivers laser modules and state-of-the-art electro-optic systems. From in-house chip design and assembly, through fiberoptic handling and precision automated optic assembly, to fully integrated high power, high quality laser systems built on Civan’s core technologies and competencies. Civan is backed by top investors in Israel.
HOMELAND SECURITY
3rd Eye Systems
Company type: private
Location: Israel
On-The-Move Analytics: Detecting threats from scanning or flying platforms
AGRITECH
Rootlity
Location: Israel
Rootility develops and uses innovative root-focused plant breeding methods to dramatically increase crop yields and overall agronomic performance, while preserving crop quality. Our methods are GMO-free, based on sophisticated simulation and empirical work, in ombination with well-known breeding techniques, which enable us to screen crops at a large scale and high speeds. We focus on roots as drivers of tolerance to environmental changes and performance improvement. We believe we have a distinctive advantage in bringing better products to market in a more cost-effective way. Rootility has successfully applied its technology in a number of crops in different regions globally. Large scale field trials have been conducted over a period of 5 years and commercial sales have already been initiated. Rootlity is backed by the leading Agri-tech VC in Israel, Goldstein family and angel investors.
NrGene
Location: Israel
Company type: private
NRGene, a leading genomic big data company, develops advanced computational tools and cutting- edge algorithmic models to facilitate optimal trait discovery for seed companies, animal breeders, and academia. The world’s top researchers have used NRGene’s technology for analysis of the most genetically complex and diverse species. NRGene mapped more than 120 genomes up to 2016, based only on Illumina short reads. The world’s first reference genome for bread and emmer wheat; several maize genomes; and genomes of soy, tomato and rainbow trout were among the milestones. With NRGene’s tech, a process that used to be notoriously expensive, laborious and time consuming has become turnkey, predictable, quick and affordable.
CLEAN ENERGY
Gigawatt Global Wind
BIOTECH
Biotech
Orgenesis
Location: USA
Company type: private
Orgenesis is a development stage company with a novel therapeutic approach in the treatment of diabetes by correcting malfunctioning organs with new functional tissues created from the patient’s own existing organs. Orgenesis employs a molecular and cellular approach directed at converting liver cells into functional insulin-producing cells as a treatment for diabetes. This new therapeutic approach is called Autologous Insulin Producing (AIP) cell transplantation.
Precise Bio
Company type: private
Location: USA
Precise Bio, a US based company, combines 2 paradigms: Regenerative Medicine and 3D Bio-Printing.
Its vision is: “Growing live & vital complicated organs for transplant, with 3D technology”. It’s disruptive technology and experienced team aims to achieve a world with no need for organ harvesting, endless waiting lists and immunosuppressive drugs for patients requiring organs to save their life. Precise-Bio, will be ready for ‘First in man’ testing within 36 months. In parallel, Precise Bio will mature the technology and reach manufacturing readiness in order to enable production of a verity of life saving organs.
Merchavia Investments
Location: Israel
Company type: public
All of Merchavia’s investments are in companies that were developed by Cleveland Clinic Innovations.
Controlling main share holders: Goldstein family
Chairman of Merchavia: Rani Lifshits
CEO of Merchavia: Eli Arad
CDX
Merchavia’s investment
Location: USA
Cleveland Diagnostics is developing a breakthrough technology to discover new class of diagnostics tests with high sensitivity and specificity for many cancers – early on, when cancer is still curable
Juventas
Merchavia’s investment
Location: USA
Juventas Therapeutics is a private, clinical stage biotechnology company developing novel non-viral gene therapies that activate natural processes to repair the body. Our product candidate, JVS-100, is a non-viral gene therapy that expresses stromal cellderived factor-1, or SDF-1, a naturally occurring signaling protein that has been shown to recruit the body’s own stem cells and promote tissue repair in a broad range of disease states.
Juventas’ therapeutic pproach is based on research originating at the Cleveland Clinic. Juventas is currently enrolling a Phase 2b study in patients with advanced peripheral artery disease.
GENERAL
Sofihub
Unisono develops revolutionary Artificial Intelligence engine for the IoT industry.
Umoove
Location: Israel
Founded in 2010, Umoove is the first ever, pure software, face and eye tracking, for any mobile device. No extra hardware needed. A unique technology (20 filed patents so far), built from ground up, that has attracted the attention of many of the biggest companies in the world.
http://www.businessinsider.com/27-hottest-israel-startups-of-2015-2015-9